Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Operating Margin for Agios Pharmaceuticals (AGIO)
Operating Margin as of May 2024 (TTM): -1,990.40%
According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -1,990.40%. At the end of 2020 the company had an Operating Margin of -161.11%.
Operating Margin history for Agios Pharmaceuticals from 2012 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2020 | -161.11% | -53.83% |
| 2019 | -348.97% | -4.81% |
| 2018 | -366.61% | -49.89% |
| 2017 | -731.60% | 157.64% |
| 2016 | -283.97% | 42.59% |
| 2015 | -199.14% | 141.34% |
| 2014 | -82.51% | -45.71% |
| 2013 | -151.98% | 66.43% |
| 2012 | -91.32% | 20.86% |
| 2011 | -75.56% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -101.74% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -101.24% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -101.13% | 🇬🇧 UK |
 Xencor XNCR | -141.63% | -92.88% | 🇺🇸 USA |
 Exelixis EXEL | 11.86% | -100.60% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -100.24% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.